| ²é¿´: 2738 | »Ø¸´: 3 | ||
guocc007ľ³æ (СÓÐÃûÆø)
|
[ÇóÖú]
½ô¼±ÇóÖú£ººÎνÏà¶Ô»ùÖÊЧӦ£¿Ôõô¼ÆË㣿
|
| RT£¬Ð¡µÜͶ¸å£¬±»Éó¸åÈËÖÊÎÊÏà¶Ô»ùÖÊЧӦ¡£¸÷λǰ±²ÄÜ·ñ¸ø½âÊÍһϺÎνÏà¶Ô»ùÖÊЧӦ£¿Ôõô¼ÆËãÄØ£¿ |
» ²ÂÄãϲ»¶
080200ѧ˶£¬»úе¹¤³Ìרҵ277·Ö£¬Çó´ø×ߣ¡
ÒѾÓÐ7È˻ظ´
377Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
295Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
086000ÉúÎïÓëÒ½Ò©298µ÷¼ÁÇóÖú
ÒѾÓÐ10È˻ظ´
0860 Çóµ÷¼Á Ò»Ö¾Ô¸¹ú¿Æ´ó 348 ·Ö
ÒѾÓÐ3È˻ظ´
²ÄÁϵ÷¼Á
ÒѾÓÐ4È˻ظ´
±¾¿Æ211ÉúÎïҽѧ¹¤³Ì085409Çóµ÷¼Á339·Ö
ÒѾÓÐ9È˻ظ´
296Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
385·Ö ÉúÎïѧ£¨071000£©Çóµ÷¼Á
ÒѾÓÐ11È˻ظ´
308Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´

°×Ë®6177
ľ³æ (СÓÐÃûÆø)
- Ó¦Öú: 72 (³õÖÐÉú)
- ½ð±Ò: 2356.8
- É¢½ð: 100
- ºì»¨: 8
- Ìû×Ó: 171
- ÔÚÏß: 64.2Сʱ
- ³æºÅ: 598662
- ×¢²á: 2008-09-10
- ÐÔ±ð: GG
- רҵ: Ò©Îï´úлÓëÒ©ÎﶯÁ¦Ñ§
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
guocc007: ½ð±Ò+2, ¡ïÓаïÖú, ºÃÓÑ˵µÄÊÇ»ùÖÊЧӦ¶ø²»ÊÇÏà¶Ô»ùÖÊЧӦ¡£¶øÎÒÎʵÄÊÇÏà¶Ô»ùÖÊЧӦ¡£ËÍÁ½¸ö½ð±Ò¹ÄÀøÒ»Ï¹þ 2012-07-26 09:32:58
xiaoxiao270: ½ð±Ò+1, 3Q 2012-07-28 14:53:11
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
guocc007: ½ð±Ò+2, ¡ïÓаïÖú, ºÃÓÑ˵µÄÊÇ»ùÖÊЧӦ¶ø²»ÊÇÏà¶Ô»ùÖÊЧӦ¡£¶øÎÒÎʵÄÊÇÏà¶Ô»ùÖÊЧӦ¡£ËÍÁ½¸ö½ð±Ò¹ÄÀøÒ»Ï¹þ 2012-07-26 09:32:58
xiaoxiao270: ½ð±Ò+1, 3Q 2012-07-28 14:53:11
|
Ò»¡¢MF(Matrix Factor£¬»ùÖÊÒò×Ó)£º peak area£¨fortified samples£©/peak area£¨analytical samples£© ¶þ¡¢IS adjusted Matrix Factor(ÄÚ±êУÕýµÄ»ùÖÊÒò×Ó) Ratios of peak area£¨Drug/IS£©£¨fortified samples£©/Ratios of peak area£¨Drug/IS£©£¨analytical samples£© MFΪ1£¬±íÃ÷Ò©ÎïµÄ²â¶¨ÎÞ»ùÖÊЧӦӰÏ죻 »ùÖÊЧӦӰÏ췶Χ£¨MF;ÄÚ±êУÕýµÄMF£©ÔÚijһ¸öÇø¼ä¿É½ÓÊÜ£»£¨0.8~1.2£© |
2Â¥2012-07-24 20:59:57
°×Ë®6177
ľ³æ (СÓÐÃûÆø)
- Ó¦Öú: 72 (³õÖÐÉú)
- ½ð±Ò: 2356.8
- É¢½ð: 100
- ºì»¨: 8
- Ìû×Ó: 171
- ÔÚÏß: 64.2Сʱ
- ³æºÅ: 598662
- ×¢²á: 2008-09-10
- ÐÔ±ð: GG
- רҵ: Ò©Îï´úлÓëÒ©ÎﶯÁ¦Ñ§
3Â¥2012-07-26 11:46:44
guocc007
ľ³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 4727.8
- Ìû×Ó: 66
- ÔÚÏß: 36.5Сʱ
- ³æºÅ: 975724
- ×¢²á: 2010-03-19
- ÐÔ±ð: GG
- רҵ: Ò©Îï·ÖÎö

4Â¥2012-07-28 09:42:57














»Ø¸´´ËÂ¥